As of 2025-09-16, the Relative Valuation of Horizon Therapeutics PLC (HZNP) is 72.72 USD. This relative valuation is based on P/E multiples. With the latest stock price at 116.30 USD, the upside of Horizon Therapeutics PLC based on Relative Valuation is -37.5%.
The range of the Relative Valuation is 47.00 - 97.78 USD.
| Range | Selected | |
| Trailing P/E multiples | 35.7x - 51.1x | 44.3x |
| Forward P/E multiples | 20.4x - 34.1x | 26.4x |
| Fair Price | 47.00 - 97.78 | 72.72 |
| Upside | -59.6% - -15.9% | -37.5% |
| Date | P/E |